pyrazinoic acid has been researched along with nad in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hada, T; Higashino, K; Moriwaki, Y; Takahashi, S; Yamamoto, T | 1 |
Fukuwatari, T; Shibata, K; Sugimoto, E | 1 |
Dartois, V; Dick, T; Gopal, P; GrĂ¼ber, G; Kaya, F; Manimekalai, MSS; Nartey, W; Ragunathan, P; Sarathy, J; Setzer, C; Yee, M | 1 |
3 other study(ies) available for pyrazinoic acid and nad
Article | Year |
---|---|
In vitro conversion of pyrazinamide into 5-hydroxypyrazinamide and that of pyrazinoic acid into 5-hydroxypyrazinoic acid by xanthine oxidase from human liver.
Topics: Humans; Liver; NAD; Pyrazinamide; Xanthine Oxidase | 1987 |
Growth-promoting activity of pyrazinoic acid, a putative active compound of antituberculosis drug pyrazinamide, in niacin-deficient rats through the inhibition of ACMSD activity.
Topics: Animals; Antitubercular Agents; Carboxy-Lyases; Diet; Eating; Injections, Intraperitoneal; Kidney; Kynurenic Acid; Liver; Male; NAD; Niacin; Pyrazinamide; Rats; Rats, Wistar; Tryptophan; Weight Gain; Xanthurenates | 2002 |
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD.
Topics: Antitubercular Agents; Binding Sites; Carbon; Carboxy-Lyases; Coenzyme A; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Models, Molecular; Mycobacterium bovis; Mycobacterium tuberculosis; NAD; Protein Binding; Protein Conformation; Pyrazinamide | 2017 |